Endoscopic Stricture Management Devices

Global Endoscopic Stricture Management Devices Market to Reach US$1.2 Billion by 2030

The global market for Endoscopic Stricture Management Devices estimated at US$904.3 Million in the year 2024, is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Bougie dilators, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$783.1 Million by the end of the analysis period. Growth in the Other products segment is estimated at 3.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$246.4 Million While China is Forecast to Grow at 8.4% CAGR

The Endoscopic Stricture Management Devices market in the U.S. is estimated at US$246.4 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$246.4 Million by the year 2030 trailing a CAGR of 8.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Endoscopic Stricture Management Devices Market – Key Trends & Drivers Summarized

Why Are Endoscopic Stricture Management Devices Essential in Gastrointestinal Treatments?

Endoscopic stricture management devices are critical tools used to treat gastrointestinal (GI) strictures, which occur when sections of the digestive tract narrow due to inflammation, scarring, tumors, or congenital conditions. These strictures can obstruct food passage, cause severe discomfort, and lead to complications such as malnutrition and bowel obstruction. Endoscopic dilation, stenting, and balloon dilation procedures are widely used to widen narrowed sections of the esophagus, small intestine, bile ducts, and colon, eliminating the need for more invasive surgeries.

The rising incidence of conditions such as esophageal cancer, Crohn’s disease, peptic strictures, and post-surgical anastomotic strictures has fueled demand for advanced stricture management solutions. Additionally, technological advancements in biodegradable stents, fully covered self-expanding metal stents (SEMS), and balloon dilation catheters have improved patient outcomes by enhancing long-term patency, reducing migration risks, and minimizing procedural complications. As minimally invasive endoscopic treatments gain popularity, the market for stricture management devices continues to expand.

What Are the Latest Innovations in Endoscopic Stricture Management?

Technological advancements in endoscopic stents and dilation devices have revolutionized stricture management by improving precision, durability, and patient safety. The development of biodegradable and drug-eluting stents has enhanced long-term efficacy, reducing the need for repeat procedures. Self-expanding metallic and polymer-based stents have been refined to offer better flexibility, reduced migration, and improved lumen patency.

Additionally, AI-powered endoscopic imaging and real-time navigation systems are assisting gastroenterologists in identifying strictures more accurately and predicting patient-specific treatment responses. The integration of robot-assisted endoscopic techniques has also improved procedural accuracy, particularly in complex or recurrent strictures. With increasing demand for minimally invasive and patient-friendly GI treatments, the market for next-generation stricture management devices is set to grow significantly.

What Is Driving the Growth of the Endoscopic Stricture Management Devices Market?

The growth in the endoscopic stricture management devices market is driven by rising gastrointestinal disease prevalence, increasing adoption of non-surgical treatment approaches, and advancements in stenting and balloon dilation technologies. The growing preference for outpatient and ambulatory endoscopic procedures, fueled by cost savings and faster patient recovery, has further expanded market opportunities.

Additionally, the introduction of AI-driven endoscopic assessment tools, patient-specific stent customization, and biodegradable materials has enhanced treatment precision and reduced post-procedural complications. The expansion of specialized gastroenterology clinics, regulatory approvals for innovative stents, and increasing healthcare investments in minimally invasive therapies are expected to further propel market growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Endoscopic Stricture Management Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (Bougie dilators, Other products); Application (Esophageal, Colonic, Pyloric, Biliary, Other applications); End-User (Hospitals, Ambulatory surgery centers, Other End-Users)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Becton, Dickinson and Company
• Boston Scientific Corporation
• CONMED Corporation
• Cook Medical
• Endo-Flex GmbH
• Hobbs Medical, Inc.
• M.I. Tech
• Medi-Globe GmbH
• Medtronic plc
• Merit Medical Systems
• Micro-Tech Endoscopy
• Olympus Corporation
• Ovesco Endoscopy AG
• PanMed US
• STERIS plc
• Taewoong Medical Co., Ltd.
• Teleflex Incorporated
• US Endoscopy (a subsidiary of STERIS)
• W. L. Gore & Associates
• Zhejiang Chuangxiang Medical Technology Co., Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.